CD34 and myeloproliferative disorder: To explore the relevance of these findings to human disease, we performed methylcellulose assays on CD34+-enriched blood samples from patients with clinically determined MPN and post-MPN AML with IDH2R140Q and JAK2V617F mutations (Table 1).